Autoimmune diseases are where your immune system attacks healthy cells in your body. The global autoimmune disease diagnosis market is segmented by product and service, test type, disease, end user, and regions. The market saw a healthy growth in the past few years.

What the market looks like?

The global autoimmune disease diagnosis market is expected to reach USD 4.73 Billion by 2022 from USD 3.09 Billion in 2017, at a CAGR of 8.9%. The growing incidence of autoimmune diseases along population, technological advancements in analyzing devices, increasing access to medical insurance in the US, and increasing healthcare expenditure are key factors driving the growth of this market.

By product and service, the global market is segmented into consumables and assay kits, instruments, and service. The consumables and assay kits segment is estimated to account for the largest market share of the global market in 2017. Factors driving the growth of this segment include the increasing adoption of consumables and assay kits and bulk buying of these products.

By test type, the market is classified into routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and other tests. The routine laboratory tests segment is estimated to account for the largest share of the global autoimmune disease diagnosis market during the next five years. Increasing adoption of routine tests in the diagnosis of chronic disease is very high which is driving the growth of this market.

By disease, the market is classified systemic lupus erythematosus, rheumatoid arthritis, Sjögren’s syndrome, thyroiditis, scleroderma, and other diseases. In 2017, the rheumatoid arthritis segment is estimated to account for the largest share of the global market. The growth of this segment is mainly driven by the increasing incidences of the disease.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174826519

What Driving the Market Growth?

The growth of the global market for autoimmune disease diagnosis is primarily influenced by the following factors:

1. Rising Geriatric Population
2. Increase in the Volume of Surgeries and Sports-Related Injuries
3. Increasing Awareness About the Medical Implications of Adhesions

Geographical Growth Scenario Of Autoimmune Disease Diagnosis Market:

The global autoimmune disease diagnosis market is dominated by North America, followed by Asia. North America will continue to dominate the global market during the forecast period. However, Asia is expected to witness the highest CAGR during the forecast period with growth centered at China, India, and Japan. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the market in this region.

Leading Market Players and Strategies Adopted by Them:

Major industry players launched innovative products to maintain and improve their position in the autoimmune disease diagnosis market. Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), HYCOR Biomedical (US), Siemens AG (Germany), Bio-Rad Laboratories, Inc. (US), and Abbott Laboratories (US) have been identified as the key players in this market.

These companies have a broad product portfolio with comprehensive features and have also launched innovative products. These leaders have products for all end users in this market, a strong geographical presence, and focus on continuous product innovations.

Read more: https://www.marketsandmarkets.com/PressReleases/autoimmune-disease-diagnosis.asp